Marketresearchnews

Saturday, 20 October 2018

Oral Thrush Market 2018 Market Challenge, Driver, Trends & Forecast to 2023

Market Scenario
Oral thrush also called as oral candidiasis is an infection of the mouth caused by strains of the Candida species. Candida albicans is the most commonly implicated organism, which occurs naturally in about 50% of the world's population as a normal component of the oral microbiota. However, Candida albicans is an opportunistic pathogen and it accounts for about 50% of oral candidiasis cases across the globeand other strains of candida such as C. tropicalis, C. glabrata and C. albicans, account for over 80% of cases collectively. Increasing prevalence of HIV has increased immunodeficiency in the patient, which makes the patient more susceptible to dubliniensis and C. geotrichium. Furthermore, the infection is also detected in hospitalized patients, smokers, immune-compromised individuals due to diseases such as diabetes, cancer, and Down syndrome.

Apart from common symptoms such as white layer of infection on the tongue and other parts of oral mucosa, it includes burning sensation, metallic, acidic, salty or bitter taste in the mouth, difficulty swallowing (dysphagia), and hoarseness of the voice etc.

Various factors affects the prevalence of Candida such as high humidity, and temperature. Females are more prone to develop the condition as compared to males. Moreover, people wearing dentures, consumption of high carbohydrates containing diet, suffering from xerostomia (dry mouth) are at a higher risk of developing oral thrush. Other factors affecting the market for oral thrush is age with newborns and aged population having the least prevalence while infants having the highest.

Market development represents the best strategy for the market growth. The market will witness exponential growth over the review period owing to advanced antibacterial mouth rinses and improving palatability and quality of oral hygiene products. The developing regions of Asia and the Middle East are attracting new players owing to less regional competition for the oral thrush product. Increase in risk factors such as high fat containing and sugar rich foods, growing screening, increasing infant population. On the other hand, the market may experience a slow growth on account of lack of awareness and misdiagnosis of the disease.

The global oral thrush market is expected to reach USD 9.5 billion by 2023, and the market is projected to grow at a CAGR of ~ 4.4 % during the forecast period 2017-2023.

Intended Audience

Global oral thrush treatment manufacturers & suppliers
Research and development (R&D) companies
Hospitals and clinics
Academic institutes and universities

Segments:
The global oral thrush market has been segmented on the basis of type, diagnosis, treatment, and end user.

Based on type, the market has been segmented as pseudomembranous, erythematous, hyperplastic, and others.
Based on diagnosis, the market has been segmented as examination, biopsy, endoscopy, and others.
Based on treatment, the market has been segmented as anti-fungal, immune-modulators, and others.
Based on the end user, the market has been segmented as hospitals & clinics, academic and research, and others.

Regional Analysis
The Americas accounts for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new products in the US drives the oral thrush market. Also, concentration of major healthcare companies in the developed countries of this region coupled with the larger market for oral hygiene products is adding fuel to the market growth. Moreover, the US expend high on the healthcare, which accounts for 16% of GDP also cruises the sale of oral thrush treatment.

Europe is the second largest market in the world due to high income and strong healthcare penetration. European market growth is led by countries such as Germany and France. The UK is expected to be the fastest growing market over the assessment period. Furthermore, the high influence of media and the rise in the awareness regarding oral hygiene coupled with the high per capita income of the population drive the European oral thrush market.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector and large unmet needs during the forecast period. South East Asian countries such as Vietnam, Thailand, and Malaysia are projected to contribute highly to the market growth.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for will be Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development. However, Africa has the highest unmet needs in the world and cost-effective products will be the key to dominate the African market. First comer will take advantage and establish the dominance in the African market, which will be difficult to overcome by any new player due to the smaller market size and market value of the African market for oral thrush.

Key Players in the Global Oral Thrush Market
Some of key players profiled in the report are Bayer AG, Teva Pharmaceuticals, Stellar Pharma, Pfizer Inc., Wockhardt Ltd., Ranbaxy Laboratories Limited, Bristol Laboratories, Glenmark Pharmaceuticals, GlaxoSmithKline Plc., and others.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4417

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Laxatives Market in depth study and analysis published, 2018

Market Scenario:

Laxatives are drugs used in the treatment of constipation and to promote evacuation of bowels by increase bowel movements. Although there is a difference in their mechanism of action but all laxatives increase the water content of faeces and thereby ease their removal.

The market for laxatives is a bloated market with the growing demand due to rise in risk factors associated with constipation. The risk factors include sedentary lifestyle, overweight, long working hours which affect consumption patterns etc. The other factors driving the market are availability of laxatives as over the counter medicines without prescription and the falling prices of most laxatives due to rise of synthetic products. The off label use of laxatives also results in greater demand than is needed due to wasteful and inappropriate use of these medicines and results in laxative abuse. Laxative abuse is a condition in which the body is unable to expel faces due to excessive stimulation by chronic use of laxatives. Chronic use of laxatives may also results in disturbance of electrolyte balance, hypotension, hypokalaemia, rhabdomyolysis, steatorrhoea, etc.

The market restraints are the side effects associated with the medicines such as their habit forming potential, flatulence, abdominal cramps, dehydration etc. The market is flooded with plethora of products with dubious claims which reduces the credibility of the market by raising the cost of selection. The relaxed regulations has induced many dubious producers to flood the market with spurious and even harmful products which is the greatest threat to the market.

Study Objectives Global Laxatives market:

To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the global laxatives market
To provide insights about factors affecting the market growth
To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future prospective
To provide country level analysis of the market for segments by mechanism of action, by type, by route of administration
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

Key Players for Global Laxatives market:

AstraZeneca plc, Boehringer Ingelheim GmbH, Bayer AG, GlaxoSmithKline, Abbott Laboratories, Takeda Pharmaceutical Company and others

Segments:

Global Laxatives market has been segmented on the basis of mechanism of action into bulk forming, emollient, stimulant, osmotic and others. On the basis of type the market has been segmented into organic and synthetic. On the basis of route of administration the market has been segmented into oral and rectal.

Regional Analysis of Global Laxatives market:

Globally North America is the largest market for global Laxatives market. Europe is the second-largest market for global laxatives market. However the developing regions market particularly Asia Pacific will be the fastest growing and will be the key to the future.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2772

Pregnancy Test Kits Market in depth study and analysis published, 2018

Market Synopsis of Global Pregnancy Test Kits Market:

Market Scenario:

Pregnancy test kits are medical devices which are used to identify the possibility of pregnancy in females. The device senses tiny amount of HCG (Human Chorionic Gonadotrophin; female pregnancy hormone), the amount of which increases during early stages of pregnancy in the female body. Continuous technological advancements in pregnancy test kits, rising demand of self-contained and quick test results and growing age of first pregnancy are some of the major issues, which are likely to bolster the growth of global pregnancy test kits market over the forecast period.

However, rising new small players with a very little or no medical equipment business history, and a huge price gap between the top players and small un-organized players’ are some of the factors which are hindering the growth of global pregnancy test kits market in the future.

Study objectives:

To provide detail analysis of the market structure along with estimated forecast for the next 6 years about various segments and sub-segments of the global pregnancy test kits market.
To provide insights about factors affecting the market growth.
To analyze the global pregnancy kits market based on various factors- price analysis, supply chain analysis, Porters Five Force Analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries - Americas, Europe, Asia-Pacific along with Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future growth prospect.
To provide country level analysis of the market’s segments which includes by type and by product and by end users.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive landscape of the market.
To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments currently taking place in the global pregnancy kits market.

Intended Audience

Global pregnancy test kits providers, manufacturers & suppliers
Research and development (R&D) companies
Government research laboratories
Independent research laboratories
Government and independent regulatory authorities
Market research and consulting service providers
Academic institutes and universities

Segments:

The Global Pregnancy Test Kits Market is segmented on the basis of type of test, product and end users. Based on the type of test, the market has been segmented as blood test for HCG, Urine test for HCG and others. Based on products, the market has been segmented into digital devices, line indicators which are further segmented into strips, cassettes and mid-stream devices and others. Further on the basis of end users, the market has been segmented into hospitals, clinics, households and others.

Regional analysis

North America accounts for the maximum market share of the pregnancy test kits market and the market is expected to increase continuously in coming years. This can be attributed to increasing pool of aware females along with need for household determination of pregnancy. Advancing technologies within the pregnancy test kits or instant pregnancy tests is also driving the market and will see strategic growth over the next five years. Asia pacific with the upcoming developments in healthcare and increasing awareness and per capita income is expected to command the maximum market share of the market.

Key players of Global Pregnancy Kits Market:

Key players profiled in the report are Alere Inc. (US), Prestige Brands Holdings, Inc, (US), Quidel Corporation (US), Procter & Gamble Co., (Germany), Piramal Enterprises (India), Cardinal Health (US), and Confirm Biosciences (US).

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2982

Friday, 19 October 2018

Thyroid Disorder Market 2018 Global– Key Players, Size, Trends, Growth- Analysis To 2023

Market Synopsis of Global Thyroid Disorder Market

Market Scenario:

Thyroid gland convert iodine taken from food into triiodothyronine (T3) and thyroxine (T4). These hormones are released into the blood stream and play an important role in the regulation of metabolism, growth and development, intelligence deficit etc. Thyroid hormones also affect fertility, kidney functions and cardiac functions as well. According to the international thyroid society almost 20 million Americans suffer from some form of thyroid disease and more than 12 percent of the U.S. population will develop a thyroid condition during their lifetime. The World Health Organization (WHO) has identified that iodine deficiency can easily be prevented which if not done can cause brain damage.

The market driving factors for world thyroid disorder market are growing screening and prevalence of thyroid disorders, good reimbursement for treatment and increasing awareness of implications of thyroid disorders.

Other factors driving the market’s growth are rise in risk factors such as obesity, diabetes, auto immune diseases etc. For example the percentage of the population diagnosed with hashimoto’s thyroiditis is growing and its occurrence is twice in patients who have diabetes. Increasing focus of developing regions’ governments on the healthcare sector is also driving the thyroid disorders treatment market. Rise in the number of thyroid cancer cases and the high cure rates of thyroid cancer is another factor driving the growth of this market.

The market’s restraints are the costs associated with the treatment and the rise of alternative medicines for the treatment of thyroid disorders. However, side-effects associated with the current medication is the most critical restraint. Thyroid disorders treatment medication have a low therapeutic index which is the difference between safe and effective dose.

The market for thyroid disorders is a consolidated market with few companies dominating the market. Among the hypothyroidism drugs Levothyroxine, Cytomel and Liothyronine top the market, while hyperthyroidism market leaders include imidazole and propacil.

Taking all the factors into consideration, we expect the global thyroid disorder market which was US$1990 million in 2016 to reach US$2400.8 million by 2022, growing with a CAGR of 3.1%.

Study Objectives Global Thyroid Disorder Market:

To provide detail analysis of the market structure along with forecast for the next 6 years of various segments and sub-segments of the global thyroid disorder market
To provide insights about factors affecting the market growth
To analyze the market based on various analyses which includes price analysis, supply chain analysis, Porters Five Force analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries which includes Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future growth prospect.
To provide country level analysis of the market for segments which includes by treatment (drugs and supplements, diagnostics and surgery), by disease indication (hypothyroidism, hyperthyroidism and other), by route of administration (oral, injectable and others) and by end users (hospitals and home use)
To provide overview of key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments globally.

Key Players for Global Thyroid Disorder Market:

Some of the key players in this market are namely Allergan, Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., RLC LABS, AbbVie, Mylan and others.

Segments:

Global thyroid disorder market has been segmented on the basis of treatment which comprises of drugs and supplements, diagnostics and surgery. On the basis of disease indication; market is segmented into hypothyroidism, hyperthyroidism and other. On the basis of route of administration the market is segmented into oral, injectable and others. On the basis of end users the market is segmented into hospitals and home use.

Regional Analysis of Global Thyroid Disorder Market:

Globally America is the largest market for thyroid disorder and Europe is the second-largest market. Developed regions are expected to lose their market leadership in future due to growing Asia Pacific region which is expected to be the fastest growing region in thyroid disorder market. This region will be led by China and India. Africa is expected to be a moderately growing market in the global thyroid disorder market.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2747

India CRO Market Trends, Analysis and Review during 2018 To 2023

Market Synopsis of India CRO Market:

Market Scenario:

A contract research organization (CRO) provides support to the pharmaceutical, biotechnology, and medical device industries for specific services on a contract basis. The services may be clinical research, product development such as drug development or process development such as bio analytical assay development. A CRO may also provide management services such as clinical trials management, and pharmacovigilance.

India is emerging as a top destination for contract research organizations for the following reasons

India’s acceptance of International guidelines and intellectual property rights
Presence of diverse types of climatic conditions thus allowing stability studies to be performed with ease in one destination
Educated and accessible human resource in India
Presence of diverse ethnic pool thus enabling diverse sample for clinical trials
Low operational cost due to cheap human resource
Availability of largest pool of patients and large hospitals

The other factors favoring the market are efforts by the regulatory authorities such as Director Controller General of India (DCGI), Indian Council of Medical Research (ICMR), Directorate General of Foreign Trade (DGFT), Department of Biotechnology (DBT) to create an amenable climate for research in India.

The market constraints are growing concern for security especially data security and patient security, lack of collaboration between universities and industry etc. The compromises done by some Indian CROs on ethical and technical standards are the greatest market threat.

Taking all factors into consideration, we expect the India CRO market to reach around $1973.82 million from $1000 million in 2016, by the end of the forecast period at a CAGR of ~12.00%.

Study Objectives India CRO Market:

To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Indian CRO market
To provide insights about factors affecting the market growth
To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments for India CRO market
To provide country level analysis of the market with respect to the current market size and future prospective
To provide country level analysis of the market for segments by service type, by therapeutic applications, by end users and other sub segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

Key Players for India CRO Market:

Some of the key players in this market are: Quintiles IMS Holdings, Inc., Syngene, Pharmaceutical Product Development, LLC., Siro Clinpharm, Clininvent Research Pvt. Ltd., VIMTA, Bilcare Limited, Aizant Drug Research Solutions Private Limited, Piramal Pharma Solutions, Synapse Labs Pvt Limited, Eurofins Scientific, Laurus Labs., Neuland Laboratories Ltd, and PAREXEL International Corporation

Segments:

India CRO market has been segmented on the basis of service types which comprises clinical trials, product development, process development, post-marketing surveillance, quality monitoring and others. On the basis of therapeutic application; market is segmented into oncology, cardiovascular, neurology, nephrology and urology, and others. On the basis of end users; market is segmented into pharmaceutical/biopharmaceutical companies, medical devices companies and academic institutes.

Regional Analysis of India CRO Market:

The healthcare sector of India is divided between differential geographic regions and states. The South India and western India account for a major share of the Indian CRO market. However of late the CRO industry is shifting to the North. The reasons for this shift is the concentration of regulatory authority such as Director Controller General of India (DCGI) office, Indian Council of Medical Research (ICMR), Directorate General of Foreign Trade (DGFT), Department of Biotechnology (DBT) etc. Also the costs are lower in North India and the genetic pool is more diverse.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2927

Anal Fissure Treatment Market to Observe Significant Growth by 2018

An expert on premium research reports, Market Research Future has added a report titled " Anal Fissure Treatment Market Research Report- Global Forecast till 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top Market Players across the Globe.

The global anal fissure treatment market is expected to attain USD 2.6 Bn and capture a CAGR of 5.2% over the forecast period of 2017-2023. An anal fissure is a painful medical condition where the anal canal has been torn and is accompanied by pain and bleeding during and after defecation. There has been a steep rise in the incidence of anal fissures which is, in turn, propelling the market for anal fissure treatment. The anal fissure market is primarily driven by growing prevalence of constipation, diarrhea, tuberculosis, carcinoma, acquired immunodeficiency syndrome (AIDS), and inflammatory bowel disease, etc. The rise in the geriatric population who are at a higher risk of developing anal fissures owing to decreased blood flow to the anus is also a chief driver of the market. Bad eating habits, leading to stressful and hectic life, and sedentary lifestyle observed among all age groups are even driving the market for anal fissure treatment.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3841

Segments:

The global anal fissure treatment market is segmented on the basis of drugs and surgery. Based on drugs, the market has been segmented as topical nitroglycerin, calcium channel blockers, stool softeners, and others. Based on the surgery, the market has been segmented as lateral internal sphincterotomy, anal dilation and others.

Regional analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global anal fissure treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest growing region because of large unmet needs which is led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.

Regional Analysis

The key markets of the global anal fissure treatment market are North America, Europe, Asia-Pacific, and the Middle East & Africa. Asia-Pacific is estimated to lead the market owing to unmet medical needs of a large population pool and falling prices of anal fissure treatment, growing number of hospitals and increased expenditure on healthcare due to rise in disposable income in the region. The US accounts for a significant share of the market due to favorable reimbursement landscape and advancement in the field of healthcare technology in the region. The Gulf nations mainly Saudi Arabia and UAE are the major contributors of the Middle East and Africa market. However, the economically and socially backward regions of Africa are expected to exhibit staggered growth owing to low penetration of healthcare facilities in the region.

Competitive Landscape

The key players operating in the market include SRS Pharmaceuticals Pvt. ltd., Takeda Pharmaceutical Company Limited, Novasep, PurduePharma L.P., Healthy Life Pharma Private Limited, Troikaa Pharmaceuticals Ltd., Taj Pharmaceuticals Ltd., Geri-Care Pharmaceuticals, and others.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/3841

Detailed Table of Contents:

Introduction

1.1 Definition

1.2 Scope Of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research:

Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

Macroeconomic Indicators

Conclusion

10.1 Key Findings

10.1.1 From Ceo’s Viewpoint

10.1.2 Unmet Needs Of The Market

10.2 Key Companies To Watch

10.3 Prediction Of Anal Fissure Treatment Industry

Appendix

...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/3841

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Digital Wound Measurement Devices Market to show steady growth, 2018

Global Aromatherapy Market based on various factors - price analysis, supply chain analysis, Porters Five Force Analysis etc., Key Developement and Aromatherapy Industry Overview by 2023

Market Research Future Presents granular study report of "Global Digital Wound Measurement Devices Market Research Report- Global Forecast To 2023" Providing overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies and drawing a competitive landscape of the market.

Market Scenario

The global digital wound measurement devices market is expected to witness a positive growth during the forecast period. Digital wound measurement devices enable monitoring of chronic wounds and deliver the appropriate drug dose to speed up the process of healing. Chronic wounds if not treated on time can lead to severe infections and amputations. Hence, digital wound measurement devices allow delivering tailored treatments after the 2D or 3D assessment of the infection and inflammation. The increasing number of patients suffering from chronic wounds drives the market growth. According to the Intermountain Healthcare (2017), 6.5 million people in the US suffer from chronic wounds. Diabetic wounds are severe, and the process of healing is very long and eventually may lead to amputations. Hence factors such as growing diabetic patients, rising geriatric population, and an increasing number of surgeries are major factors influencing the growth of the market. The emergence of smartphones, rapid use of advanced digital tools, and the advent of telehealth for wound care will also contribute for the market to grow.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6289

However, factors such as, the inability of the device to provide additional information about wounds such as moistness or exudation and high costs of digital devices are expected to restrict the market growth during the forecast period.

Segmentation

The global digital wound measurement devices market is segmented on the basis of wound type, product, and end-user. The digital wound measurement devices market, by wound type is sub-segmented into a diabetic ulcer, chronic wounds, burns, incisional, and traumatic. The product segment is sub-segmented into contact wound measuring devices and non-contact wound measuring devices.

On the basis of end-user, the market is segmented into hospitals, clinics, and ambulatory surgical centers.

On the basis of region, the global digital wound measurement devices market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Key players

Some of the key players for the global digital wound measurement devices market are WoundRight Technologies Tissue Analytics, Parable Health, ARANZ Medical Limited, eKare, Inc, KCI, an Acelity Company, WoundMatrix, Inc., WoundZoom Inc., Kent Imaging Inc., WoundRight Technologies, LLC, WoundVision, LLC, Hitachi Healthcare Americas, and Smith & Nephew plc.

Regional Market Summary

The digital wound measurement devices market is dominated by North America owing to the rising prevalence of chronic wounds and technological advancements in the healthcare sector. In June 2018, KCI, an Acelity Company announced the launch of Nurse2Nurse (N2N) Mobile App for wound care nurses. The app allows interactions with clinicians and shares credible insights and information for better patient care.

It is estimated that Europe was the second largest in the global digital wound measurement devices market. The increasing technological advancement and research for wound care along with government support in Europe drive the market growth in this region. The European Wound Management Association will conduct its 29th conference by June 2019 in Gothenburg, Sweden in the presence of several international wound management communities with the common goal of improving the care of wound patients.

Asia-Pacific was projected to be the fastest growing region for the global digital wound measurement devices market. Key factors such as rising geriatric population, growing diabetic patient pool, high incidence chronic wounds, and developing healthcare infrastructure drive the market in this region. According to the Asian Diabetes Prevention Initiative, 60% of the world diabetic population is in Asia. This provides favorable backgrounds for the market to grow in Asia.

The Middle East and Africa holds the least share of the global digital wound measurement devices market due to the presence of stringent government policies and poor economic growth. However, growing awareness and increasing investments by private market players in this region can boost the market growth.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/6289

Detailed Table of Contents:

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/6289

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com